1. Plasma cadmium is associated with increased risk of long-term kidney graft failure
- Author
-
Ramón Rodrigo, Michele F Eisenga, Rosa G.M. Lammerts, Jan IJmker, Dion Groothof, Martin H. de Borst, Gerjan Navis, Daan J Touw, Riemer H. J. A. Slart, Camilo G. Sotomayor, Stephan J. L. Bakker, Ilja M. Nolte, Joppe J Vodegel, Stefan P Berger, Tim J Knobbe, Groningen Kidney Center (GKC), Lifestyle Medicine (LM), Groningen Institute for Organ Transplantation (GIOT), Life Course Epidemiology (LCE), Cardiovascular Centre (CVC), Translational Immunology Groningen (TRIGR), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Value, Affordability and Sustainability (VALUE), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Groningen Research Institute for Asthma and COPD (GRIAC), Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Pharmaceutical Analysis, and Medicinal Chemistry and Bioanalysis (MCB)
- Subjects
Graft Rejection ,0301 basic medicine ,medicine.medical_specialty ,CHELATION-THERAPY ,cadmium ,BIOMARKERS ,030232 urology & nephrology ,Urology ,Renal function ,RENAL DYSFUNCTION ,UNITED-STATES ,BLOOD CADMIUM ,Kidney ,Nephrotoxicity ,tubular damage ,03 medical and health sciences ,chemistry.chemical_compound ,long-term graft failure ,0302 clinical medicine ,Risk Factors ,medicine ,Humans ,oxidative stress ,Prospective Studies ,Risk factor ,Prospective cohort study ,Creatinine ,kidney function decline ,HYPERTENSION ,business.industry ,Graft Survival ,Hazard ratio ,ENVIRONMENTAL LEAD-EXPOSURE ,PROGRESSIVE DIABETIC-NEPHROPATHY ,Kidney Transplantation ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Nephrology ,Toxicity ,SURVIVAL ,Kidney Diseases ,business ,kidney transplant recipients - Abstract
The kidney is one of the most sensitive organs to cadmium-induced toxicity, particularly in conditions of long-term oxidative stress. We hypothesized that, in kidney transplant recipients, nephrotoxic exposure to cadmium represents an overlooked hazard for optimal graft function. To test this, we performed a prospective cohort study and included 672 outpatient kidney transplant recipients with a functioning graft of beyond one year. The median plasma cadmium was 58 ng/L. During a median 4.9 years of follow-up, 78 kidney transplant recipients developed graft failure with a significantly different distribution across tertiles of plasma cadmium (13, 26, and 39 events, respectively). Plasma cadmium was associated with an increased risk of graft failure (hazard ratio 1.96, 95% confidence interval 1.56-2.47 per log(2) ng/L). Similarly, a dose-response relationship was observed over increasing tertiles of plasma cadmium, after adjustments for potential confounders (donor, recipient, transplant and lifestyle characteristics), robust in both competing risk and sensitivity analyses. These findings were also consistent for kidney function decline (graft failure or doubling of serum creatinine). Thus, plasma cadmium is independently associated with an increased risk of long-term kidney graft failure and decline in kidney function. Further studies are needed to investigate whether exposure to cadmium represents an otherwise overlooked modifiable risk factor for adverse long-term graft outcomes in different populations.
- Published
- 2021